EBO Bio Solution Ltd and UKABCS Announce Strategic Partnership to Empower Global Researchers
London, October 2025 —
The UK Association for Biotechnology and Computational Science (UKABCS) proudly announces a landmark strategic partnership with EBO Bio Solution Ltd (UK) — a UK-based company at the forefront of biotechnology, computational chemistry, and AI-powered scientific education.
This collaboration represents a pivotal step toward creating a unified scientific ecosystem that combines education, research, and innovation under one framework, connecting researchers across continents and empowering them with access to cutting-edge computational tools, analytical services, and global opportunities.
A Vision Rooted in Science, Driven by Collaboration
Modern research increasingly depends on data-driven discovery, advanced modeling, and artificial intelligence. Yet access to these technologies remains uneven, particularly in developing regions.
The partnership between UKABCS and EBO Bio Solution aims to bridge this gap by offering researchers — regardless of geography or institutional resources — access to tools, training, and collaborative platforms that meet global standards of excellence.
Under the agreement, EBO Bio Solution Ltd will serve as the Computational Research and Educational Partner of UKABCS, supporting the Association’s key initiatives across grants, capacity-building, international conferences, and digital innovation.
Areas of Collaboration
The collaboration will unfold across five main dimensions that directly support UKABCS’s mission of empowering global researchers:
- AI-Driven Education and Training
EBO Bio Solution will develop and deliver training programmes, workshops, and mentorship sessions focused on computational drug design, bioinformatics, molecular modeling, and data analytics. These programmes will integrate artificial intelligence to simplify complex analyses and make learning more interactive and accessible. - Advanced Research Infrastructure
Through this partnership, UKABCS members and grantees will gain access to EBO’s advanced research platforms, including SciAnalyzer, a next-generation analytical software for data interpretation, visualization, and dose–response modeling that surpasses traditional tools such as GraphPad Prism. - Joint International Conferences and Publications
The two organizations will co-host scientific conferences in the UK, Egypt, and other regions, providing global stages for researchers to present their findings. Selected outputs will be published through the International Journal of Biotechnology and Computational Science (IJBTCS) — an official UKABCS publication. - Research Collaboration and Grant Support
EBO Bio Solution will collaborate with UKABCS on funded research projects in drug discovery, nanotechnology, genomics, and computational biology, providing technical validation and AI-based analytical support for grant recipients. - Innovation through Artificial Intelligence
The partnership will explore the development of customized AI models to automate molecular simulations, predict drug–target interactions, and enhance reproducibility and transparency in scientific research.
Empowering Researchers Through Knowledge and Access
For many scientists, the biggest barrier to innovation is not the lack of ideas — but the lack of access to the right tools and collaborative environments.
Through this partnership, both institutions are committed to democratizing access to computational resources, enabling students, early-career researchers, and established academics to engage in high-quality, data-driven science.The collaboration will ensure that researchers in regions such as the Middle East, North Africa, and Latin America can participate in the same global ecosystem as those in Europe and the UK, thereby strengthening international equity in scientific discovery.
Statements from Both Sides
Dr. Israa M. Shamkh, Founder and Managing Director of EBO Bio Solution Ltd, expressed her vision for the collaboration:
“This partnership marks a defining moment for global research accessibility. Together with UKABCS, we are transforming how science is learned, practiced, and shared. Our mission at EBO Bio Solution has always been to make computational chemistry and biotechnology tools available to everyone — not just to those with institutional privilege. Through this collaboration, we are empowering the next generation of researchers to turn data into discovery.”
Mr. Khizar Hayat, Director of UKABCS, highlighted the significance of this alliance:
“Partnering with EBO Bio Solution Ltd expands UKABCS’s capacity to provide cutting-edge resources to our members and research partners worldwide. This collaboration perfectly aligns with our commitment to transparency, fairness, and excellence in science. Together, we are building bridges between innovation and opportunity.”
Towards a Global Ecosystem of Computational Excellence
The UKABCS–EBO Bio Solution partnership symbolizes the convergence of science and technology for the greater good. By integrating AI, computational methods, and educational innovation, both organizations aim to accelerate the translation of scientific data into actionable knowledge that drives progress in medicine, biotechnology, and environmental research.The first phase of the collaboration, launching in early 2026, will include:
- Joint capacity-building programmes and fellowships.
- Access to shared computational resources for funded projects.
- Integration of AI analytics within UKABCS research initiatives.
- International exchange programmes between UK and Middle Eastern researchers.
Through this strategic partnership, UKABCS and EBO Bio Solution Ltd reaffirm their shared belief that science should be inclusive, innovation should be accessible, and education should be transformative.
Together, they are shaping a future where data becomes discovery, knowledge becomes power, and collaboration becomes the foundation of scientific progress.